Ovid Therapeutics Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Ovid Therapeutics Stock Summary

Ovid Therapeutics competes with CytomX Therapeutics, Spero Therapeutics, Instil Bio, NextCure, and Assembly Biosciences. Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company was incorporated in 2014 and is headquartered in New York, New York. Ovid Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 44 people.

Ovid Therapeutics Key Financial Ratios

Ovid Therapeutics Key Balance Sheet Accounts

Ovid Therapeutics Key Cash Accounts

Ovid Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Ovid Therapeutics's current stock value. Our valuation model uses many indicators to compare Ovid Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ovid Therapeutics competition to find correlations between indicators driving Ovid Therapeutics's intrinsic value. More Info.Ovid Therapeutics is regarded third in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Ovid Therapeutics' Return On Equity is projected to slightly decrease based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Ovid Therapeutics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Ovid Therapeutics Systematic Risk

Today, most investors in Ovid Therapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Ovid Therapeutics' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Ovid Therapeutics growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Ovid Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Ovid Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Ovid Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Ovid Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Ovid Therapeutics's daily price indicators and compare them against related drivers.

When running Ovid Therapeutics' price analysis, check to measure Ovid Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ovid Therapeutics is operating at the current time. Most of Ovid Therapeutics' value examination focuses on studying past and present price action to predict the probability of Ovid Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ovid Therapeutics' price. Additionally, you may evaluate how the addition of Ovid Therapeutics to your portfolios can decrease your overall portfolio volatility.